Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
CHA University
Fudan University
German Cancer Research Center
Institut National de la Santé Et de la Recherche Médicale, France
Institut National de la Santé Et de la Recherche Médicale, France
CHA University
Shanghai Proton and Heavy Ion Center
German Cancer Research Center
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
University of Nebraska
Australian & New Zealand Children's Haematology/Oncology Group
Changhai Hospital
Anhui Provincial Hospital
Centre Hospitalier Universitaire de Nīmes
University of Nebraska
University Hospital, Toulouse
Vall d'Hebron Institute of Oncology
Rennes University Hospital
RenJi Hospital
Alliance for Clinical Trials in Oncology
Sohag University
Fox Chase Cancer Center
Case Comprehensive Cancer Center
University Hospital, Bordeaux
Translational Oncology Research International
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center
Hospices Civils de Lyon
Norwegian University of Science and Technology
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Case Comprehensive Cancer Center
National Cancer Institute (NCI)